Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors

• Main Authors: Lana Schmidt (Author), Ching An Wang (Author), Vardhaman Patel (Author), David Davidson (Author), Samaneh Kalirai (Author), Ankita Panda (Author), Lauren Seigel (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Apremilast, the first oral targeted treatment for moderate to severe psoriasis, is associated with diarrhea, nausea, and vomiting, which have contributed to treatment discontinuation. This study describes early apremilast discontinuation rates in patients with psoriasis, includ...